Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 6, 1996, Pages 579-584

  Müller Ladner, Ulf ^a   Gross, Volker ^a   Andus, Tilo ^a   Gschwendtner, Heidi ^a   Roth, Michael ^a   Caesar, Inka ^a   Schölmerich, Jürgen ^a   Lang, Bernhard ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Anti neutrophil cytoplasmic antibodies; Autoantibodies; Crohn's disease; Immunoglobulin subclasses; Ulcerative colitis

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; ISOTHIOCYANIC ACID; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; FLUORESCENCE; GRANULOCYTE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PANCREAS JUICE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS;

EID: 0029900881     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199606000-00016     Document Type: Article

References (43)

1. Spiegelberg HL: Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol 1974, 19:259-294.
2. Shakib F, Stanworth DR: Human IgG subclasses in health and disease. Part I and II. Ric Clin Lab 1980, 10:463-479, 561-580.
3. Oxelius VA: Immunoglobulin G (IgG) subclasses and human disease. Am J Med 1984, 76:7-18.
4. Heiner DC: Significance of immunoglobulin G subclasses. Am J Med 1984, 76:1-6.
5. Rubin RL, Tang F-L, Chan EKL, Pollard KM, Tsay G, Tan EM: IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjögren's syndrome, and drug-induced autoimmunity. J Immunol 1986, 137:2528-2534.
6. Winkler TH, Henschel TA, Kalies I, Baenkler HW, Skvaril F, Kalden JR: Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus. Clin Exp Immunol 1988, 72:434-443.
7. Stocker W, Otte M, Ulrich S, Normann D, Finkbeiner H, Stöcker K, et al.: Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 1987, 22 (Suppl. 139):41-52.
8. Goischke EM, Zilly W: Clinical importance of organ-specific antibodies in ulcerative colitis and Crohn disease. Z Gastroenterol 1992, 30:319-324.
9. Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990, 86:202-210.
10. Rump JA, Schölmerich J, Groß V, Roth M, Helfesrieder R, Rautmann A, et al.: A new type of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in active colitis but not in Crohn's disease. Immunobiology 1990, 181:406-413.
11. Duerr RH, Targan SR, Landers CJ, Larusso NF, Lindsay KL, Wiesner RH, et al.: Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991, 100:1385-1391.
12. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH: Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992, 33:657-662.
13. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BME, Peña AS, et al.: Serum antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment. Gut 1993, 34:46-50.
14. Gross WL, Schmitt WH, Csernok E: ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993, 91:1-15.
15. Oudkerk Pool M, Roca M, Reumaux D, Bouma G, Peña AS, Colombel JF, et al.: The value of pANCA as a serological marker for ulcerative colitis in different European regions. Eur J Gastroenterol Hepatol 1994, 6:399-403.
16. Colombel J-F, Reumaux D, Duthilleul P, Noel L-H, Gower-Rousseau C, Paris J-C, et al.: Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Gastroenterol Clin Biol 1992, 16:656-660.
17. Snook JA, Chapman RW, Fleming K, Jewell DP: Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989, 76:30-33.
18. Klein R, Eisenburg J, Weber P, Seibold F, Berg PA: Significance and specifity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 1991, 14:1147-1152.
19. Schlenker T, Apenberg S, Raedsch R, Andrassy K, Plachky J, Kommerell B: Antineutrophile zytoplasmatische Antikörper bei chronisch-entzündlichen Darmerkrankungen. Dtsch Med Wochenschr 1992, 117:1463-1468.
20. Vidrich A, Landers C, Sandborn B, Weisner RH, Lindor KD, Targan SR: IgG subclass distinguishes between PSC and UC ANCA [abstract]. Gastroenterology 1993, 104:A19.
21. Hardarson S, Douglas LaBrecque DR, Mitros FA, Neil GA, Goeken JA: Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. Am J Clin Pathol 1993, 99:277-281.
22. Seibold F, Weber P, Jenss H, Wiedmann KH. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Gut 1991, 32:1192-1197.
23. Brouwer E, Cohen Tervaert W, Horst G, Huitema MG, Van der Giessen M, Limburg PC, et al.: Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic antibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991, 83:379-386.
24. Esnault VLM, Ronda N, Jayne DRW, Lockwood CM: Association of ANCA isotype with disease expression. J Autoimmun 1993, 6:197-205.
25. Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. BMJ 1989, 298:82-86.
26. Best WR, Becktel JM, Singelton JW, Kern F: Development of a Crohn's disease activity index: national co-operative Crohn's disease study. Gastroenterology 1976, 70:439-444.
27. Ellerbroek PM, Oudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BM, von dem Borne AE, et al.: Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol 1994, 47:257-62
28. Gigase PL, van Outryve MJ, van Cotthem KA, de Clerck LS, Pelckmans PA, Stevens WS, et al.: IgA and IgG class antineutrophil cytoplasmic antibodies in inflammatory bowel diseases [abstract]. Gastroenterology 1993, 104:A706.
29. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CGM, et al.: Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophospate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989, 84:1577-1587.
30. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, et al.: Association between active Wegener's granulomatosis and anti-cytoplasmic antibodies. Arch Intern Med 1989, 149:2461-2465.
31. Jennette JC, Falk RJ: Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides. Am J Kidney Dis 1991, 17:184-187.
32. Esnault VLM, Jayne DRW, Weetman AP, Lockwood CM: IgG subclass distribution and relative functional affinity of antimyeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up. Immunology 1991, 74:714-718.
33. Volta U, Molinaro N, Fratangelo D, Bianchi FB: IgA subclass antibodies to gliadin in serum and intestinal juice of patients with coeliac disease. Clin Exp Immunol 1990, 80:192-195.
34. Engström P-E, Sundin U, Lavö B, Norhagen G, Hàllgren R, Smith CIE, et al.: Class and subclass-associated specificity differences of anti-gliadin antibodies from mucosa and serum. Immunology 1992, 77:604-608.
35. Scott MG, Nahm MH, Macke K, Nash GS, Bertovich MJ, MacDermott RP: Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls. Clin Exp Immunol 1986, 66:209-215.
36. MacDermott RP, Nash GS, Bertovich MJ, Mohrmann RF, Kodner IJ, Delacroix DL, et al.: Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease. Gastroenterology 1986, 91:379-385.
37. MacDermott RP, Nahm MH: Expression of human immunoglobulin G subclasses in inflammatory bowel disease. Gastroenterology 1987, 93:1127-1129.
38. MacDermott RP, Nash GS, Auer IO, Shlien R, Lewis BS, Madassery I, et al.: Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease. Gastroenterology 1989, 96:764-768.
39. Halstensen TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P: Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 1990, 98:1264-1271.
40. Kett K, Rognum TO, Brandtzaeg P: Mucosal subclass distribution of IgG-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 1987, 93:919-924.
41. Huizinga TW, van Kemenade F, Koenderman L, Dolman KM, von dem Borne AE, Tetteroo PA, et al.: The 40-kDa Fc gamma receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J Immunol 1989, 142:2365-2369.
42. Sarvas H, Rautonen N, Sipinen S, Makela O: IgG subclasses of pneumococcal antibodies-effect of allotype G2m(n). Scand J Immunol 1989, 29:229-237.
43. Quaderi MA, Jewell DP: IgG subclasses in inflammatory bowel disease. Gut 1991, 32:A1259.